pyrroles has been researched along with pyrazolopyridine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chin, HF; De La Cruz, EM; Islam, K; Kapoor, TM; Olivares, AO; Saunders, LP | 1 |
| Agrawal, K; Annadurai, N; Das, V; Džubák, P; Hajdúch, M | 1 |
| Duan, Y; Li, X; Liu, X; Tang, Q; Wang, C; Wang, L; Xiao, Z; Zhao, B; Zheng, P; Zhu, W | 1 |
1 review(s) available for pyrroles and pyrazolopyridine
| Article | Year |
|---|---|
Microtubule affinity-regulating kinases are potential druggable targets for Alzheimer's disease.
Topics: Alzheimer Disease; Antigens, Bacterial; Azepines; Bacterial Proteins; Humans; Methylene Blue; Neurons; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyrazoles; Pyridines; Pyrroles; Staurosporine; tau Proteins | 2017 |
2 other study(ies) available for pyrroles and pyrazolopyridine
| Article | Year |
|---|---|
A myosin V inhibitor based on privileged chemical scaffolds.
Topics: Animals; Enzyme Inhibitors; Humans; Indoles; Kinetics; Mice; Myosin Type V; Oxindoles; Pyrazoles; Pyridines; Pyrimidines; Pyrroles; Structure-Activity Relationship | 2010 |
Discovery of novel pyrrolopyrimidine/pyrazolopyrimidine derivatives bearing 1,2,3-triazole moiety as c-Met kinase inhibitors.
Topics: Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Cell Survival; Drug Design; Drug Screening Assays, Antitumor; G2 Phase Cell Cycle Checkpoints; Hep G2 Cells; Humans; M Phase Cell Cycle Checkpoints; MCF-7 Cells; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-met; Pyrazoles; Pyridines; Pyrimidines; Pyrroles; Structure-Activity Relationship; Triazoles | 2018 |